Drug Type Small molecule drug |
Synonyms 5,7-Dihydroxyflavanone, 7-Dihydroxyflavanone, DL-0108 |
Target |
Mechanism 5α-reductase inhibitors(Steroid 5 alpha reductase inhibitors), AR agonists(Androgen Receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H12O4 |
InChIKeyURFCJEUYXNAHFI-UHFFFAOYSA-N |
CAS Registry68745-38-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Pinocembrin | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Stroke | Phase 2 | CN | 29 Apr 2014 | |
Acute Ischemic Stroke | Phase 2 | CN | 02 Dec 2013 | |
Ischemic stroke | Phase 2 | CN | 01 Jun 2013 | |
Cerebral Infarction | Phase 2 | CN | - | |
Cerebral Infarction | Phase 2 | CN | - |